WebbNDMA was recently discovered in medicinal products containing ranitidine, and recall procedures have been introduced. Responsibilities of marketing authorisation holders Marketing authorisation holders are responsible for the quality, safety and efficacy of their products, including the quality of the APIs, excipients and raw materials used in the …

Medicines containing the active ingredient ranitidine hydrochloride …

Webb21 nov. 2024 · In early April 2024, the FDA issued a warning requesting the withdrawal from the market of all medicinal products containing ranitidine. Based on this warning, the agencies in Honduras and Panama took the same action, requesting the withdrawal of medicines containing ranitidine from their respective markets (updated 28th April) WebbRanitidine (as hydrochloride) 25 mg/mL Solution for Injection (IM/IV) Aglotac: DRP-6135: Ranitidine (as hydrochloride) 25 mg/mL (50 mg/2 mL) Solution for Injection: Alflux: DRP … mark hannam mother in tas

Presence of nitrosamine impurities in medicinal products.

Webb2 feb. 2024 · Zantac lawsuits began when the popular ranitidine-based heartburn medicine was pulled from store shelves. The FDA, in response to new studies demonstrating the possibility of ranitidine breaking down into a carcinogen called NDMA, requested retailers to pull ranitidine-containing products, including Zantac, from their shelves. WebbProducts affected Further information Useful links. Advice for consumers and caregivers. If you are taking a medicine containing ranitidine, you can continue to take this for short term use. If you have been prescribed ranitidine, you can continue to take the medicine that has been dispensed to you by your pharmacist. Webb28 nov. 2024 · Ranitidine is a well known H2 blocker antihistaminic drug used for symptomatic relief of heartburn, indigestion, acid indigestion, peptic ulcer and hyperacidity. mark hannay scroll finance